PENTREXCILINA
- Product NDC
- 69517-155
- 11-digit product format
- 695170155
- Labeler code
- 69517
- Product ID
- 69517-155_083396b6-6a36-ffc7-e063-6294a90ad8e2
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Healthlife of USA
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-01-05
- Substance
- ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE
- Active strength
- 325; 5; 15 mg/1; mg/1; mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 69517-155-72 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 69517-155-06 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 69517-155-72 | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 69517-155-06 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- PENTREXCILINA
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 325 mg/1 |
| PHENYLEPHRINE HYDROCHLORIDE | 5 mg/1 |
| DEXTROMETHORPHAN HYDROBROMIDE | 15 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 362O9ITL9D | Internal UNII lookup |
| 04JA59TNSJ | Internal UNII lookup |
| 9D2RTI9KYH | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1367205 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| ae9ada14-0ec8-4c01-a874-237f2108936a | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e4e263da-1c53-440f-bb80-b7a575843b5a | Product name | 1 | 20260313 |
| d2168cac-a261-415a-9c78-3522859fa720 | Product name | 3 | 20251124 |
| 05a8cdd1-eeb8-409e-b938-0778225eca7d | Product name | 4 | 20250221 |
| e5b5c132-b15d-435b-9faa-2f74e5cadcf9 | Product name | 8 | 20250220 |
| f489e8f3-5c9e-4818-b539-a73587edcfc7 | Product name | 2 | 20240229 |
| 0f7ae452-206d-4fc4-868d-56fc47074084 | Product name | 1 | 20231011 |
| b5abe2e3-39a1-43eb-9bff-f3c1653fe3df | Product name | 2 | 20190930 |
| e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814 | Product name | 3 | 20150910 |
| 42f3c020-f1b3-89bc-7bdc-e1f10e680485 | Product name | 1 | 20140508 |
| e949165d-714d-e548-2b76-0cb5def16f30 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 69517-155-06 | 2023-02-23 | PENTREXCILINA |
| 69517-155-72 | 2023-02-23 | PENTREXCILINA |
| 69517-155-06 | 2023-01-30 | PENTREXCILINA |
| 69517-155-72 | 2023-01-30 | PENTREXCILINA |
| 69517-155-06 | 2021-12-03 | PENTREXCILINA |
| 69517-155-72 | 2021-12-03 | PENTREXCILINA |
| 69517-155-06 | 2020-01-31 | PENTREXCILINA |
| 69517-155-72 | 2020-01-31 | PENTREXCILINA |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69517-155-06 | PENTREXCILINA | 2 in 1 POUCH | TABLET | 2 | 8 | |
| 69517-155-06 | PENTREXCILINA | 6 in 1 PACKAGE | TABLET | 6 | 8 | |
| 69517-155-72 | PENTREXCILINA | 2 in 1 POUCH | TABLET | 2 | 8 | |
| 69517-155-72 | PENTREXCILINA | 72 in 1 PACKAGE | TABLET | 72 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69517-155 | PENTREXCILINA (ACETAMINOPHEN, PHENYLEPHRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE) TABLET [HEALTHLIFE OF USA] | 8 | Current NDC, Legacy NDC, 4 package rows | 20231021_ae9ada14-0ec8-4c01-a874-237f2108936a.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nuvicare DayTime and NightTime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE | NUVICARE LLC | f5764925-c586-40e4-8252-24d92389af01 | 2025-06-09 | Warnings | M012 |
| Nuvicare NightTime Cold and Flu Softgel | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | NUVICARE LLC | 2a29f0ed-d86b-4787-84e0-f7a8c5e7581f | 2025-06-09 | Warnings | M012 |
| Nuvicare DayTime and NightTime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, DOXYLAMINE SUCCINATE | NUVICARE LLC | 7fa8e4ad-95cb-4905-90db-d53b3bc87c41 | 2025-06-09 | Warnings | M012 |
| Vaporizing Steam Liquid | MEDICATED COUGH SUPPRESSANT | NeilMed Pharmaceuticals Inc. | 36cf6218-adb8-9d8b-e063-6394a90a49a0 | 2025-06-05 | Warnings | M012 |
| Geri-Tussin DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | Geri-Care Pharmaceuticals, Corp | 7e2fb43c-a7f1-4c1d-a700-7c6510999c03 | 2025-06-05 | Warnings | M012 |
| CHILDRENS ROBITUSSIN COUGH AND COLD LONG-ACTING | CHLORPHENIRAMINE MALEATE, DEXTROMETRORPHAN HBR | Haleon US Holdings LLC | becb4025-b63e-f2ea-9d11-d51fdf4e5c13 | 2025-06-04 | Warnings | M012 |
| Diphenhydramine HCL STRAWBERRY FLAVOR | DIPHENHYDRAMINE HCL | Innovida Pharmaeutique Corporation | 7eb709a5-c587-4f1d-bc2d-576d07a3a3bf | 2025-06-04 | Warnings | M012 |
| Children Allergy Relief Bubblegum flavor | DIPHENHYDRAMINE HCL | TARGET CORPORATION | 69d33f77-06e1-48fa-a516-892fdf11bb1c | 2025-06-03 | Warnings | M012 |
| oxymetazoline hydrochloride | OXYMETAZOLINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | fd058e2b-5445-e416-e053-6394a90a611b | 2025-06-03 | Warnings | M012 |
| Major Nasal Decongestant | OXYMETAZOLINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 36b1a7e0-c8b9-0890-e063-6394a90ab13a | 2025-06-03 | Warnings | M012 |
| COLD, FLU and SORE THROAT RELIEF | ACETAMINOPHEN 650 MG, DEXTROMETHORPHAN HBR 20 MG, GUAIFENESIN 400 MG, PHENYLEPHRINE HCL 10 MG | BETTER LIVING BRANDS, LLC | 202d60a8-83da-5afc-e063-6394a90ad779 | 2025-05-31 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HCL | TARGET CORPORATION | f935341f-1e33-d78e-e053-6294a90a348e | 2025-05-30 | Warnings | M012 |
| Diphenhydramine HCl | DIPHENHYDRAMINE HCL | AARNA USA INC. | 365bb414-8425-a900-e063-6394a90aa887 | 2025-05-30 | Warnings | M012 |
| Childrens Allergy | DIPHENHYDRAMINE HYDROCHLORIDE | P & L Development, LLC | 8559be55-8b00-4353-8e26-b5dff2ada806 | 2025-05-30 | Warnings | M012 |
| Daytime Nighttime Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE | Walmart Inc. | 35da8429-1f83-9e81-e063-6294a90a3515 | 2025-05-23 | Warnings | M012 |
| MAXIMUM STRENGTH COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | TARGET CORP | 9dfef3dc-dbc8-659a-e053-2995a90a8c3b | 2025-05-21 | Warnings | M012 |
| Adult Tussin | GUAIFENESIN | Camber Consumer Care | 896d2540-279a-4405-b176-acbff56303e5 | 2025-05-20 | Warnings | M012 |
| Nuvicare NightTime Cold and Flu Softgel | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | NUVICARE LLC | 37a88914-6234-4191-86f5-103c396c52af | 2025-05-20 | Warnings | M012 |
| Nuvicare DayTime Cold and Flu Softgel | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE | NUVICARE LLC | 1ea15426-4f3d-4a97-a590-6bd73bc6cbcd | 2025-05-19 | Warnings | M012 |
| Quality Choice Nasal | OXYMETAZOLINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION | 3833e781-f6ee-4c6d-8756-d8ea2293a1f2 | 2025-05-19 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1367205 | acetaminophen 325 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Tablet | PSN | ae9ada14-0ec8-4c01-a874-237f2108936a | 8 |
| 1367205 | acetaminophen 325 MG / dextromethorphan hydrobromide 15 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SCD | ae9ada14-0ec8-4c01-a874-237f2108936a | 8 |
| 1367205 | APAP 325 MG / dextromethorphan hydrobromide 15 MG / phenylephrine hydrochloride 5 MG Oral Tablet | SY | ae9ada14-0ec8-4c01-a874-237f2108936a | 8 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 69517-155-06 | 69517015506 | 6 POUCH in 1 PACKAGE (69517-155-06) / 2 TABLET in 1 POUCH | 6 pouch | 2018-01-05 | 0000-00-00 | No | No | Current |
| 69517-155-72 | 69517015572 | 72 POUCH in 1 PACKAGE (69517-155-72) / 2 TABLET in 1 POUCH | 72 pouch | 2018-01-05 | 0000-00-00 | No | No | Current |